GulloK. (2004) ‘Nearly half of U.S. adults closely following news coverage of Vioxx withdrawal’, Harris Interactive Health Care News, 3(24), 1–5.
5.
KravitzR.WilkesM. (2004) A UC Davis School of Medicine Publication for Alumni, Friends and Physicians. UC Regents. Available at: http://www.ucdm.ucdavis.edu (Accessed 2005).
6.
The Pink Sheet (2004), ‘AstraZeneca ads claim ‘better’ and ‘best’: Will FDA protest?The Pink Sheet66(44), 29.
CasellsA. (2002) ‘Consumer drug advertising leads to MD backlash in Holland’, Canadian Medical Association Journal, 167(7), 793.
10.
FoxS. (2004) Pew Internet and American Life Project, www.pewinternet.org (Accessed 2005).
11.
Press Office The Greens/EFA in the European Parliament (2003) Council Agreement on Pharmaceutical Review, www.greens-efa.org (Accessed January 2005).
12.
Forum Diabetologiczne (2004) ‘Naukowy biuletyn medyczny firmy Servier Polska’, Scientific Medical Bulletin of Servier Poland, 4(7), 9.
13.
TatoñJ. (2002) ‘Postêpowanie w cukrzycy typu2 oparte na dowodach’ (Type 2 diabetes management based on medicine evidence), Wydawnistwo Lekarskie PZWL, Warsaw, Poland, p. 140.
14.
PasagianMacaulay A.BaschC.E.ZybertP.WylieRosett J. (1997) ‘Ophthalmic knowledge and beliefs among women with diabetes’, Diabetes Education, July, 433–437.
15.
NorlundA.ApelqvistJ.BitzenP.O. (2001) ‘Cost of illness of adult diabetes mellitus underestimated if comorbidity is not considered’, Journal of Internal Medicine250(1), 57.